ACM
IRON icon

Asymmetry Capital Management’s Disc Medicine IRON Stock Holding History

Asymmetry Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,469
Closed -$1.15M – 30
2021
Q3 		$1.15M Buy
+9,469
New +$1.29M 0.69% 26

Other funds holding IRON

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Asymmetry Capital Management's IRON Position: Q4 2021 in Review

Asymmetry Capital Management sold out of Disc Medicine (IRON) in Q4 2021, closing a stake of 9,469 shares — an estimated $1.15M sold.

Asymmetry Capital Management first reported a position in IRON in Q3 2021 and held it in 1 quarter. The position peaked at $1.15M in Q3 2021. 62 funds tracked by Wall St. Rank hold IRON as of Q4 2021.

  • Asymmetry Capital Management reported no remaining Disc Medicine position as of Q4 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 9,469 Disc Medicine shares in Q4 2021, an estimated $1.15M.
  • Asymmetry Capital Management first reported a position in Disc Medicine in Q3 2021 and held it in 1 quarter.
  • Asymmetry Capital Management's Disc Medicine position peaked at $1.15M in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.